Last reviewed · How we verify
Prevention of migraine in adults
Approved treatments
- Rimegepant/BHV3000 · Pfizer
- Rimegepant 25 MG · Pfizer
- rimegepant 75 mg ODT · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of migraine in adults patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of migraine in adults treatment landscape brief
- Prevention of migraine in adults treatment updates RSS
Frequently asked questions about Prevention of migraine in adults
What drugs treat Prevention of migraine in adults?
Tracked treatments include Rimegepant/BHV3000, Rimegepant 25 MG, rimegepant 75 mg ODT.
What is the treatment for Prevention of migraine in adults?
Standard treatment for Prevention of migraine in adults includes Rimegepant/BHV3000, Rimegepant 25 MG, rimegepant 75 mg ODT. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of migraine in adults patent cliff · Prevention of migraine in adults CI report
- Treatment: Rimegepant/BHV3000 · Pfizer
- Treatment: Rimegepant 25 MG · Pfizer
- Treatment: rimegepant 75 mg ODT · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing